Paul Staid
About Paul Staid
Paul Staid is the VP of Cell Therapy Supply Chain at Bristol-Myers Squibb, with over 25 years of experience in the pharmaceutical and biotechnology industries.
Company
Paul Staid currently works at Bristol-Myers Squibb in New Jersey. He serves as the Vice President, Cell Therapy Supply Chain, overseeing operations and strategic initiatives related to cell therapy products within the company. Bristol-Myers Squibb is renowned for its innovative solutions in the pharmaceutical and biotechnology industries, making Staid's role crucial in maintaining and enhancing the company's supply chain efficiency.
Title
Paul Staid holds the position of Vice President, Cell Therapy Supply Chain at Bristol-Myers Squibb. In this role, he is responsible for leading the cell therapy supply chain operations, ensuring that the processes remain efficient and compliant with industry standards. His extensive background in strategic sourcing and supply chain management supports his current responsibilities.
Education and Expertise
Paul Staid earned his MBA in Finance & Operations from Cornell Johnson Graduate School of Management between 1993 and 1995. He also holds a Bachelor of Science in Mechanical Engineering from Cornell University, completed from 1986 to 1990. His educational background, combined with over 25 years of experience in the pharmaceutical and biotechnology industries, has equipped him with a strong foundation in both technical and management disciplines.
Background
Paul Staid has accumulated over 25 years of experience in the pharmaceutical and biotechnology industries. His career began at ICG Commerce as Director of Strategic Sourcing from 1995 to 2001, followed by his role as Senior Director of Contract Manufacturing Solutions at PTC from 2001 to 2003. He then served as Senior Director at Wyeth Pharmaceuticals from 2004 to 2009, focusing on biotech strategic sourcing before joining Bristol-Myers Squibb. At Bristol-Myers Squibb, he initially served as VP, Biologics Product Strategy & Operations from 2009 to 2017 before transitioning to his current role.
Achievements
Paul Staid had a significant impact on Bristol-Myers Squibb's biologics portfolio growth during his tenure as VP, Biologics Product Strategy & Operations. At Wyeth Pharmaceuticals, he played a key role in enhancing biotech sourcing strategies, which contributed to the company’s operational efficiencies. While at PTC, he managed contract manufacturing solutions and optimized manufacturing processes, demonstrating his expertise in strategic sourcing and supply chain management.